Literature DB >> 1832835

Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts.

H K Kole1, R J Resnick, M Van Doren, E Racker.   

Abstract

Fructose 2,6-bisphosphate (F-2,6-P2) stimulated glycolysis in cell-free extracts of both normal and ras-transfected rat-1 fibroblasts. The extract of the transformed cell glycolyzed more rapidly in both the absence and the presence of F-2,6-P2 than the extract of the parent fibroblast. Addition of mitochondrial ATPase (F1) or inorganic phosphate (Pi) further stimulated lactate production in both cell lines. F-2,6-P2 stimulated the 6-phosphofructo-1-kinase (PFK-1) activity in extracts of normal and transfected cells. The activity in extracts of transformed cells tested with a fructose 6-phosphate regenerating system was considerably higher than in the extract of normal cells. Stimulation of PFK-1 activity by cAMP of both cell lines was not as pronounced as that by F-2,6-P2. In the absence of F-2,6-P2 the PFK-1 activity was strongly inhibited in the transformed cell by ATP concentrations higher than 1 mM, whereas in the normal cell only a marginal inhibition was noted even at 2 or 3 mM ATP. F-2,6-P2 reversed the inhibition of PFK-1 by ATP. Nicotinamide adenine dinucleotide (NAD) at 100 microM (in the presence of 2 mM ATP and 1 microM F-2,6-P2) stimulated PFK-1 activity only in the transformed cell, whereas nicotinamide adenine dinucleotide phosphate (NADP) inhibited PFK-1 activity (in the presence or absence of 1 microM F-2,6-P2) in extracts of both cell lines. No previous observations of stimulation or inhibition by NAD or NADP on PFK-1 activity appear to have been reported. A threefold increase in the intracellular concentration of F-2,6-P2 was observed after transfection of rat-1 fibroblast by the ras oncogene. We conclude from these data that the PFK-1 activity of ras-transfected rat-1 fibroblasts shows a greater response to certain stimulating and inhibitory regulating factors than that of the parent cell.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1832835     DOI: 10.1016/0003-9861(91)90084-v

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  20 in total

1.  Uncharged tRNA-phosphofructokinase interaction in amino acid deficiency.

Authors:  M Rabinovitz
Journal:  Amino Acids       Date:  1996-06       Impact factor: 3.520

Review 2.  Novel therapeutic targets of tumor metabolism.

Authors:  Rigel J Kishton; Jeffrey C Rathmell
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 3.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

4.  Expression of mitochondrial genes and DNA-repair-related nuclear genes is altered in xeroderma pigmentosum fibroblasts.

Authors:  X Xia; D Werner; O Popanda; H W Thielmann
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 5.  Structure-based drug design: from nucleic acid to membrane protein targets.

Authors:  Magdalena M Dailey; Chayanendu Hait; Patrick A Holt; Jon M Maguire; Jason B Meier; M Clarke Miller; Luigi Petraccone; John O Trent
Journal:  Exp Mol Pathol       Date:  2009-01-31       Impact factor: 3.362

Review 6.  Hypoxia, glucose metabolism and the Warburg's effect.

Authors:  Ramon Bartrons; Jaime Caro
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

Review 7.  The molecular determinants of de novo nucleotide biosynthesis in cancer cells.

Authors:  Xuemei Tong; Fangping Zhao; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2009-02-05       Impact factor: 5.578

Review 8.  Cancer's craving for sugar: an opportunity for clinical exploitation.

Authors:  S Yeluri; B Madhok; K R Prasad; P Quirke; D G Jayne
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-05       Impact factor: 4.553

Review 9.  Targeting the metabolic microenvironment of tumors.

Authors:  Kate M Bailey; Jonathan W Wojtkowiak; Arig Ibrahim Hashim; Robert J Gillies
Journal:  Adv Pharmacol       Date:  2012

Review 10.  Is cancer a disease of abnormal cellular metabolism? New angles on an old idea.

Authors:  Ralph J DeBerardinis
Journal:  Genet Med       Date:  2008-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.